Endologix Inc

Industry:	Medical Devices & Equipment
Revenues:	$27.8 Million
Employees:	168

Description

Endologix, Inc. develops, manufactures, sells and markets minimally invasive therapies for the treatment of vascular disease. The Company’s products are catheter-based alternative treatments for abdominal aortic aneurysm (AAA). AAA is a weakening of the wall of the aorta, an artery of the body. The Powerlink System is a catheter and endoluminal stent graft (ELG) system. Its clinical trials demonstrate that implantation of its products will reduce the mortality and morbidity rates associated with conventional AAA surgery, as well as provide a clinical alternative to many patients that could not undergo conventional surgery. Sales of Endologix, Inc.’s Powerlink System in the United States, Europe, and South America are the primary sources of its revenues. Endologix, Inc. designed its Powerlink System, with multiple aortic cuffs, limb extensions, bifurcated main body lengths and diameters to simplify procedures, improve clinical results.
(Source: 10-K)

Products & Services

invasive treatments, endoluminal stent grafts, medical device, invasive therapies

View More Statistics

Site Statistics

Monthly Unique Visitors:	1,908
Site Rank:	602,251
Trust Rating:	Neutral
Stats by

News Archive

Endologix Announces Pricing of Public Offering of Common Stock. PR Newswire; 7/30/2009 ...July 30 /PRNewswire-FirstCall/ -- Endologix, Inc. today announced that it has entered...10 per share. The gross proceeds to Endologix, before offering expenses, from the...telephone at (800) 747-3924. About Endologix, Inc. Endologix, Inc. develops and... ...more

Endologix to Present at Three Upcoming Conferences. PR Newswire; 11/3/2009 ...Nov. 3 /PRNewswire-FirstCall/ -- Endologix, Inc. , developer of minimally invasive...visiting the investor relations section of Endologix's Web site at http://www.endologix.com/. A replay of the presentations will... ...more

Endologix Receives IDE Approval for Fully Percutaneous Approach to EVAR. PR Newswire; 11/18/2009 ...Nov. 18 /PRNewswire-FirstCall/ -- Endologix, Inc. , developer of minimally invasive...of 2010. Based on the trial results, Endologix intends to submit a future PMA supplement...on this technique. John McDermott, Endologix President and Chief Executive Officer... ...more